paclitaxel has been researched along with Cancer of Testis in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.28) | 18.7374 |
1990's | 13 (16.67) | 18.2507 |
2000's | 41 (52.56) | 29.6817 |
2010's | 18 (23.08) | 24.3611 |
2020's | 5 (6.41) | 2.80 |
Authors | Studies |
---|---|
Bellon, JR; Burstein, HJ; Dang, CT; DeMeo, M; Isakoff, SJ; Krop, IE; Partridge, AH; Tayob, N; Tolaney, SM; Tralins, J; Winer, EP; Yang, DD | 1 |
Asher, R; Connolly, EA; Forgeson, G; Goh, J; Grimison, P; Hamad, N; Heller, GZ; Hill, S; Joshi, A; Kuchel, A; Lewin, J; Liow, E; McKenzie, J; Tan, A; Tan, H; Toner, G; Tran, B; Tung, ILY; Walpole, E; Wang, Y; Weickhardt, A; Wickham, A; Winstanley, MA; Wong, V | 1 |
Dong, L; Fan, Y; Li, Q; Luo, Y; Ma, F; Wang, J; Wang, X; Xiu, M; Xu, B; Yuan, P; Zhang, P | 1 |
Cao, K; Chen, H; Gao, X; Jia, Z; Li, J; Lian, B; Liu, Z; Shao, C; Sun, Y; Wang, L; Wang, T; Wang, W; Xu, J; Yang, Q; Zhang, W | 1 |
Lassaletta, A; Madero, L; Moreno-Tejero, ML; Pelaez, I; Perez-Somarriba, M; Rozas, MI | 1 |
Albany, C; Costello, BA; Dockter, T; Einhorn, L; Lafky, JM; Le-Rademacher, J; Loprinzi, CL; Ma, C; Pachman, D; Smith, E; Staff, N; Wagner-Johnston, N; Wolfe, E | 1 |
Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W | 1 |
Richie, JP | 1 |
Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Rajec, J; Sycova-Mila, Z | 1 |
Badreldin, W; Berney, D; Chowdhury, S; Frampton, AE; Harding, V; Harland, SJ; Krell, J; Mazhar, D; Shamash, J; Stebbing, J; Wilson, P | 1 |
Chevreau, C; Culine, S; Delva, R; Eymard, JC; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Habibian, M; Journeau, F; Kerbrat, P; Laplanche, A; Linassier, C; Logothetis, C; Malhaire, JP; Mardiak, J; Martin, AL; Pagliaro, L; Reckova, M; Rolland, F; Roubaud, G; Theodore, C | 1 |
Brames, MJ; Einhorn, LH; Mulherin, BP | 1 |
Bokemeyer, C; Cathomas, R; de Wit, M; Dieing, A; Grünwald, V; Hentrich, M; Hornig, M; Lorch, A; Meiler, J; Oechsle, K; Seidel, C | 1 |
Bosl, GJ; Feldman, DR; Funt, SA | 1 |
Bokemeyer, C; Dyshlovoy, S; Gerwing, M; Hauschild, J; Honecker, F; Jacobsen, C; Oechsle, K; Oing, C; Oldenburg, J; Rohlfing, T; Venz, S; von Amsberg, G | 1 |
Alsdorf, WH; Bokemeyer, C; Oechsle, K; Oing, C; von Amsberg, G | 1 |
Beyer, J; Lorch, A | 1 |
Bokemeyer, C; Kollmannsberger, C | 1 |
Biasoni, D; Gianni, L; Milani, A; Necchi, A; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R; Stagni, S; Torelli, T | 1 |
Abonour, R; Einhorn, LH; Kesler, KA | 1 |
Boehlke, I; Bokemeyer, C; Hartmann, JT; Honecker, F; Kollmannsberger, C; Mayer, F; Oechsle, K; Waller, CF | 1 |
Hayes, JH; Ho, VT; Hornick, JL; Jagannathan, JP; O'Regan, KN; Ramaiya, N; Sneag, DB | 1 |
Kang, WK; Lee, J; Lee, S; Lim, HY; Park, JO; Park, S; Park, SH; Park, YS | 1 |
Lim, L; Powles, T; Rashid, S | 1 |
Akaza, H; Hattori, K; Hinotsu, S; Kawai, K; Miyazaki, J; Shimazui, T; Tsukamoto, S | 1 |
Driver, D; Giles, C; Harland, SJ; Haynes, R; Kanfer, EJ; McNeish, IA; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L | 1 |
Aieta, M; De Giorgi, U; Fochessati, F; Marangolo, M; Paoluzzi, L; Papiani, G; Rosti, G; Valduga, F | 1 |
Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
Argyriou, AA; Chroni, E; Ellul, J; Iconomou, G; Kalofonos, HP; Katsoulas, G; Koutras, A; Papapetropoulos, S | 1 |
Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
Mikami, K; Miki, T; Mizutani, Y | 1 |
Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Sálek, T; Sycová-Milá, Z | 2 |
Farmakis, D; Pectasides, D; Pectasides, M | 1 |
Malkowicz, SB; Rizzo, TA; Vaughn, DJ | 1 |
Bacik, J; Bajorin, D; Bosl, GJ; Donadio, A; Kondagunta, GV; Marion, S; Motzer, RJ; Sheinfeld, J | 1 |
Rexer, FH | 1 |
Mathew, P; Troncoso, P; Vakar-Lopez, F | 1 |
Fujisawa, M; Furukawa, J; Hara, I; Kumano, M; Yamada, Y; Yamanaka, K | 1 |
Kawauchi, A; Miki, T; Mizutani, Y; Nakamura, T; Nomoto, T | 1 |
Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T | 1 |
Fujisawa, M; Hara, I; Miyake, H; Takenaka, A; Yamada, Y | 1 |
Brames, MJ; Einhorn, LH; Juliar, B; Williams, SD | 1 |
Ansell, W; Berney, D; Mutsvangwa, K; Oliver, T; Powles, T; Shamash, J; Stebbing, J; Walsh, E; Wilson, P | 1 |
Brozmanová, K; Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Risnyovzská, Z; Sálek, T; Svetlovská, D; Sycová-Milá, Z | 1 |
Droz, JP; Fléchon, A | 1 |
Fukuda, H; Higashi, Y; Ichiyanagi, N; Ishioka, J; Kageyama, Y | 1 |
Inoue, H; Miki, T; Mizutani, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A | 1 |
Marwaha, S; North, SA; Venner, PM | 1 |
Galsky, MD; Kondagunta, V; Sonpavde, G | 1 |
Böhlke, I; Bokemeyer, C; Hartmann, JT; Honecker, F; Kollmannsberger, C; Mayer, F; Oechsle, K; Waller, CF | 1 |
Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gauler, T; Gerl, A; Hartmann, JT; Horger, M; Kuczyk, MA; Mayer-Steinacker, R; Metzner, B; Rick, O; Schleicher, J | 1 |
Egawa, S; Hatano, T; Ito, H; Kishimoto, K; Tomita, M; Wada, T; Yanada, S | 1 |
Bui, V; Chevreau, C; Delord, JP; Fizazi, K; Flechon, A; Geoffrois, L; Kerbrat, P; Lotz, JP; Theodore, C; Yataqhene, Y | 1 |
Necchi, A; Nicolai, N; Salvioni, R | 1 |
Bajorin, DF; Bosl, GJ; Fischer, P; Hutter, HS; Lyn, P; Motzer, RJ; Scher, HI; Schwartz, LH | 1 |
Eckhardt, S | 1 |
Beyer, J; Bokemeyer, C; Knoche, M; Natt, F; Schmoll, HJ; Souchon, R | 1 |
Gerl, A; Wilmanns, W | 1 |
Beyer, J; Bokemeyer, C; Hartmann, JT; Jonas, U; Kanz, L; Kuczyk, MA; Truss, MC | 1 |
Beyer, J; Bokemeyer, C; Harstrick, A; Kohrmann, U; Metzner, B; Ruther, U; Schmoll, HJ; Verbeek, W; Weissbach, L | 1 |
Oliver, RT | 1 |
Motzer, RJ | 2 |
Rowinsky, EK | 1 |
Cristou, A; Fox, S; Nichols, CR; Roth, BJ; Sandler, AB; Turns, M; Williams, SD | 1 |
Breder, VV; Garin, AM; Kupchan, DZ; Popov, AJ; Sidorova, NJ; Titov, DA; Tjulandin, SA | 1 |
de Mulder, PH; de Wit, R; Louwerens, M; Rodenhuis, S; Schornagel, J; Verweij, J | 1 |
Akaza, H; Hattori, K | 1 |
Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Mariani, T; Mazumdar, M; Motzer, RJ; Sheinfeld, J | 1 |
Berdel, WE; Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gerl, A; Hartmann, F; Hartmann, JT; Kanz, L; Kingreen, D; Metzner, B; Neureither, S; Rick, O; Schmoll, HJ; Schwella, N; Siegert, W; Wandt, H | 1 |
Beyer, J; Bokemeyer, C; Rick, O; Siegert, W | 1 |
Beyer, J; Rick, O; Siegert, W | 1 |
Catalano, P; Einhorn, LH; Hinton, S; Kuzel, T; Loehrer, PJ; Vaughn, D; Wilding, G | 1 |
Beyer, J; Bokemeyer, C; Hartmann, JT; Jonas, U; Kanz, L; Kollmannsberger, C; Kuczyk, MA; Truss, MC | 1 |
Kramer, RE; Mason, JI; Rainey, WE; Shay, JW | 1 |
20 review(s) available for paclitaxel and Cancer of Testis
Article | Year |
---|---|
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2022 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Clinical Trials as Topic; Disease-Free Survival; Evidence-Based Medicine; Humans; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2016 |
Platinum-refractory germ cell tumors: an update on current treatment options and developments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms | 2017 |
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2017 |
Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prognosis; Testicular Neoplasms; Time Factors; Treatment Failure; Urogenital Surgical Procedures; Vinblastine | 2008 |
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Therapeutic Equipoise | 2012 |
[The second-line chemotherapy for urological cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Male; Methotrexate; Paclitaxel; Survival Rate; Testicular Neoplasms; Treatment Outcome; Urologic Neoplasms; Vinblastine | 2005 |
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2005 |
[Progress in therapy for testicular tumors].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Irinotecan; Lymph Node Excision; Male; Paclitaxel; Taxoids; Testicular Neoplasms | 2006 |
High-dose chemotherapy for male germ cell tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms | 2006 |
[Testis germ cell tumours: which chemotherapy, for which patients?].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Seminoma; Testicular Neoplasms; Testis; Vinblastine | 2007 |
[Use of taxol in the management of malignant tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Neoplasms; Ovarian Neoplasms; Paclitaxel; Testicular Neoplasms | 1995 |
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Germinoma; Humans; Male; Paclitaxel; Testicular Neoplasms; Urinary Bladder Neoplasms | 1996 |
Future trials in germ cell malignancy (GCM) of the testis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Decision Making; Etoposide; Forecasting; Genetic Therapy; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Orchiectomy; Paclitaxel; Patient Participation; Quality of Life; Risk Factors; Safety; Salvage Therapy; Seminoma; Testicular Neoplasms | 1997 |
Paclitaxel pharmacology and other tumor types.
Topics: Alkylating Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Endometrial Neoplasms; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Neoplasms, Unknown Primary; Paclitaxel; Platinum Compounds; Sarcoma, Kaposi; Stomach Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 1997 |
Paclitaxel (Taxol) combination therapy for resistant germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Germinoma; Humans; Male; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms | 2000 |
[New combination chemotherapy in urological cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Humans; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Methotrexate; Paclitaxel; Prostatic Neoplasms; Taxoids; Testicular Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Salvage chemotherapy in relapsed germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Testicular Neoplasms; Vinblastine | 2001 |
Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
Topics: Antineoplastic Agents, Phytogenic; Humans; Male; Paclitaxel; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms | 1998 |
25 trial(s) available for paclitaxel and Cancer of Testis
Article | Year |
---|---|
Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast Cancer.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Male; Mastectomy; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Retrospective Studies; Testicular Neoplasms; Trastuzumab | 2022 |
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; International Agencies; Lenograstim; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Precision Medicine; Prognosis; Recombinant Proteins; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Humans; Ifosfamide; Leukopenia; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Taxoids; Testicular Neoplasms | 2003 |
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2004 |
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Germinoma; Humans; Male; Mediastinal Neoplasms; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Survival Analysis; Testicular Neoplasms | 2004 |
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
Topics: Administration, Oral; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Pilot Projects; Testicular Neoplasms; Uterine Cervical Neoplasms; Vitamin E | 2005 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Paclitaxel; Testicular Neoplasms; Treatment Outcome | 2005 |
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Germinoma; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Patient Selection; Probability; Prognosis; Prospective Studies; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2005 |
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Germinoma; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Gonadal Tissue; Paclitaxel; Prognosis; Prospective Studies; Retroperitoneal Neoplasms; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2005 |
Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Indiana; Kaplan-Meier Estimate; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Time Factors; Treatment Failure; Treatment Outcome | 2007 |
A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Follow-Up Studies; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Survival Analysis; Testicular Neoplasms; Time Factors; Topoisomerase I Inhibitors; Treatment Outcome | 2007 |
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Teratocarcinoma; Testicular Neoplasms | 2007 |
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Topics: Acute Kidney Injury; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2007 |
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Feasibility Studies; Gemcitabine; Humans; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 2008 |
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Survival Analysis; Testicular Neoplasms | 2007 |
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Recurrence; Testicular Neoplasms | 2008 |
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Prognosis; Salvage Therapy; Testicular Neoplasms; Vaginal Neoplasms | 1994 |
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Topics: Adult; Cisplatin; DNA Damage; Drug Resistance; Germinoma; Humans; Male; Paclitaxel; Testicular Neoplasms | 1994 |
Paclitaxel in salvage therapy for germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Cells; Carboplatin; Cisplatin; Cohort Studies; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 1997 |
A phase II trial of paclitaxel in refractory germ cell tumors.
Topics: Adolescent; Adult; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Testicular Neoplasms; Treatment Outcome | 1998 |
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Testicular Neoplasms | 1999 |
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome | 2000 |
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Germany; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Survival Rate; Testicular Neoplasms; Thiotepa | 2001 |
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Germinoma; Humans; Infusions, Intravenous; Male; Ovarian Neoplasms; Paclitaxel; Seminoma; Testicular Neoplasms; Treatment Outcome; United States | 2002 |
33 other study(ies) available for paclitaxel and Cancer of Testis
Article | Year |
---|---|
Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: A prospective cohort study with propensity-matched analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Humans; Male; Neoadjuvant Therapy; Paclitaxel; Prospective Studies; Testicular Neoplasms; Treatment Outcome; Triple Negative Breast Neoplasms | 2022 |
Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory Testicular Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Male; Neoplasm Metastasis; Paclitaxel; Sorafenib; Testicular Neoplasms; Young Adult | 2019 |
Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms | 2020 |
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Testicular Neoplasms; Young Adult | 2021 |
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Rhabdomyolysis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2017 |
Adenocarcinoma of the rete testis - a rare case of testicular malignancy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Rete Testis; Testicular Neoplasms | 2014 |
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Drug Resistance, Neoplasm; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2016 |
Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Longitudinal Studies; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 2015 |
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Registries; Retrospective Studies; Survival Analysis; Testicular Neoplasms | 2016 |
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Taxoids; Testicular Neoplasms | 2016 |
Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Epidemiologic Methods; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Salvage Therapy; Survivors; Testicular Neoplasms; Treatment Outcome | 2009 |
Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms | 2010 |
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Young Adult | 2011 |
Peritoneal relapse of testicular seminomatous germ cell tumor treated successfully with salvage chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Salvage Therapy; Seminoma; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous | 2011 |
Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Young Adult | 2011 |
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Necrosis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Testicular Neoplasms | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |
Chemosensitivity of malignant ovarian-type surface epithelial tumor of testis.
Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma, Papillary; Female; Humans; Male; Ovary; Paclitaxel; Testicular Neoplasms | 2005 |
[International study on testicular cancer: EORTC 30983: randomized phase II/III study of Taxol-BEP versus BEP in patients with Intermediate Prognosis Germ Cell Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Etoposide; Humans; Internationality; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Randomized Controlled Trials as Topic; Testicular Neoplasms; Treatment Outcome | 2005 |
Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Doxorubicin; Hemangiosarcoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Testicular Neoplasms; Treatment Outcome | 2006 |
High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. Preliminary report.
Topics: Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Feasibility Studies; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms | 2005 |
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia | 2006 |
Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Risk Factors; Testicular Neoplasms | 2007 |
The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Secondary Prevention; Testicular Neoplasms; Treatment Outcome | 2007 |
Germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms | 2007 |
[A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Splenic Neoplasms; Testicular Neoplasms | 2008 |
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?: Reply to the article "A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who fail
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Testicular Neoplasms | 2008 |
Antitumor activity of paclitaxel after failure of high-dose chemotherapy in a patient with late relapse of a non-seminomatous germ cell tumor.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Embryonal; Humans; Leukopenia; Male; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia | 1996 |
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Resistance, Neoplasm; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Testicular Neoplasms | 1996 |
Paclitaxel and cisplatin as salvage treatment in patients with non-seminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Dysgerminoma; Humans; Male; Paclitaxel; Remission Induction; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Failure; Treatment Outcome | 1998 |
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2001 |
The effects of taxol, a microtubule-stabilizing drug, on steroidogenic cells.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Alkaloids; Animals; Bucladesine; Cattle; Cell Line; Cholesterol; Leydig Cells; Male; Mice; Microtubules; Mitochondria; Paclitaxel; Pregnenolone; Progesterone; Steroids; Testicular Neoplasms | 1985 |